ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Virology
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1637643
Differential profiles of autophagy and Nrf2-mediated antioxidant response in HBeAg-positive versus HBeAg-negative chronic hepatitis B patients
Provisionally accepted- 1Qilu Hospital, Shandong University, Jinan, China
- 2Qilu Hospital of Shandong University Dezhou Hospital, Nanjing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
HBeAg seroconversion is a key focus in the current treatment of chronic hepatitis B. The processes of autophagy and oxidative stress has been found to be involved in HBV replication and translation. It remains unclear whether this process plays a promotive or inhibitory role in HBeAg seroconversion. This study aims to evaluate the role of autophagy in disease progression by quantifying Beclin1 and P62 as indicators of autophagic activity in hepatitis B patients. Additionally, the Nrf2-Keap1 pathway (nuclear factor erythroid 2-related factor 2/Kelch-like ECH-associated protein 1) serves as a marker of antioxidant defense capacity, thereby allowing an assessment of the contribution of oxidative stress to the progression of the disease in these patients. We examined the expression patterns of these factors in peripheral blood mononuclear cells (PBMCs) and plasma from both HBeAg -positive and HBeAg-negative groups (n=234) using quantitative real-time polymerase chain reaction (RT-qPCR) and ELISA. The expression levels of Beclin1 and Keap1 were significantly increased compared to those in the HBeAg-negative group (P<0.05). The expression levels of P62, Nrf2, GSH (Glutathione), GSTs(Glutathione S-transferases), and Ho-1(Heme oxygenase) were significantly decreased compared to those in the HBeAg-negative group (P<0.05). In the HBeAg(+) subgroup stratified by median levels of Beclin1, Nrf2, and Keap1, comparative analysis revealed statistically significant differences in alanine aminotransferase (ALT) expression between Beclin1-high and Beclin1-low groups (P<0.05). Specifically, the Beclin1-high group exhibited significantly higher ALT levels compared to the Beclin1-low group.In the Keap1-stratified analysis, total bilirubin (TBIL), direct bilirubin (DBIL), and indirect bilirubin (IBIL) showed statistically significant differences (P<0.05), with elevated bilirubin levels observed in the Keap1-high group.Further analysis within the HBeAg(+) subgroup demonstrated significant differences in aspartate aminotransferase (AST), DBIL, and alpha-fetoprotein (AFP) expression between Nrf2-high and Nrf2-low groups (P<0.05). The Nrf2-high group displayed higher AST and DBIL levels but lower AFP levels compared to the Nrf2-low group. Based on our findings, we conclude that autophagy and the Nrf2-Keap1 antioxidant signaling pathway play critical roles in the process of HBeAg seroconversion in chronic hepatitis B patients. Furthermore, monitoring ALT/bilirubin dynamics (linked to autophagy/oxidative stress) may assist in treatment optimization, supporting the quest for clinical cure.
Keywords: Hepatitis B virus, PBMCs, Autophagy, Oxidative Stress, Beclin1, Nrf2-Keap1, p62
Received: 29 May 2025; Accepted: 01 Sep 2025.
Copyright: © 2025 Liu, Tang, Wang, An, Zhang, Wei, cui, Fan, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Huihui Liu, Qilu Hospital, Shandong University, Jinan, China
Kai Wang, Qilu Hospital, Shandong University, Jinan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.